You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

resistant/refractory to HMA

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed/Refractory AML Trial in Suzhou (Selinexor, Homoharringtonine, Cytarabine)

Not yet recruiting
  • Relapsed/Refractory AML
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Mar 28, 2023

Molecular Abnormalities on Response of VAH vs. VEN+HMA in RR-AML

Completed
  • Relapsed Acute Myeloid Leukemia
  • +3 more
  • VAH regimen
  • VEN+HMA regimen
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Jul 8, 2022

Epilepsy Trial in Beijing (PINS Vagus Nerve Stimulator)

Recruiting
  • Epilepsy
  • PINS Vagus Nerve Stimulator
  • Beijing, Beijing, China
    Peking University First Hospital
Aug 7, 2023

Metastatic Castration Resistant Prostate Cancer Trial in United States (LAVA-1207)

Recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • LAVA-1207
  • Tampa, Florida
  • +3 more
Nov 18, 2022

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Completed
Has Results
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +8 more
  • Bevacizumab
  • Irinotecan Sucrosofate
  • Chicago, Illinois
    Northwestern University
Dec 21, 2022

Malignant Ovarian Epithelial Tumor, Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma Trial in

Recruiting
  • Malignant Ovarian Epithelial Tumor
  • +9 more
  • Akt/ERK Inhibitor ONC201
  • +2 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
May 10, 2022

Prostate Cancer, Refractory Cancer, Castration Resistant Prostatic Cancer Trial in Winston-Salem (Omeprazole 80 mg twice daily)

Recruiting
  • Prostate Cancer
  • +2 more
  • Omeprazole 80 mg twice daily
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Jan 5, 2023

Refractory Epilepsy, Epilepsy Trial in Winston-Salem (Exercise program, Health Coach, Health Information)

Terminated
  • Refractory Epilepsy
  • Epilepsy
  • Exercise program
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Dec 4, 2022

Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer, Fallopian Tube Cancer Trial in Orlando, Albuquerque

Recruiting
  • Platinum-resistant Ovarian Cancer
  • +6 more
  • olvimulogene nanivacirepvec
  • +3 more
  • Orlando, Florida
    AdventHealth Cancer Institute
Sep 1, 2022

Hormone-refractory Prostate Cancer Trial (AMX-500)

Not yet recruiting
  • Hormone-refractory Prostate Cancer
  • (no location specified)
Aug 11, 2023

Schizophrenia Trial in Shanghai (sodium valproate with Clozapine, modified electroconvulsive therapy(MECT) with Clozapine,

Completed
  • Schizophrenia
  • sodium valproate with Clozapine
  • +3 more
  • Shanghai, Shanghai, China
    Shanghai Mental Health Center
Sep 1, 2022

Platinum-refractory Ovarian Carcinoma, Platinum-resistant Ovarian Cancer Trial in Rochester, Helsinki (TILT-123, Pembrolizumab)

Recruiting
  • Platinum-refractory Ovarian Carcinoma
  • Platinum-resistant Ovarian Cancer
  • TILT-123
  • Pembrolizumab
  • Rochester, Minnesota
  • +1 more
Aug 12, 2022

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Germany, United States (Emavusertib, Azacitidine, Venetoclax)

Active, not recruiting
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Tampa, Florida
  • +8 more
Apr 5, 2022

Ovarian Cancer, Relapsed or Refractory, Chiauranib Trial in Shanghai (chiauranib, Placebo, Paclitaxel)

Recruiting
  • Ovarian Cancer
  • +3 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 7, 2022

Osteosarcoma Trial in China, Korea, Republic of (Sulfatinib, Etoposide, Isophosphamide)

Not yet recruiting
  • Osteosarcoma
  • Beijing, Beijing, China
  • +4 more
Oct 19, 2022

Androgen-Independent Prostatic Cancer, Androgen-Independent Prostatic Tumors, Prostate Cancer Recurrent Trial (lorigerlimab,

Not yet recruiting
  • Androgen-Independent Prostatic Cancer
  • +8 more
  • lorigerlimab
  • +2 more
  • (no location specified)
May 4, 2023

Transcranial Magnetic Stimulation, Drug Resistant Epilepsy, Cerebellum Trial (transcranial magnetic stimulation)

Not yet recruiting
  • Transcranial Magnetic Stimulation
  • +2 more
  • transcranial magnetic stimulation
  • (no location specified)
Mar 29, 2023

Treatment-resistant Depression, MDD Trial in Taipei (Prolonged intermittent theta burst stimulation (piTBS), 20Hz rTMS, sham

Recruiting
  • Treatment-resistant Depression
  • Major Depressive Disorder
  • Prolonged intermittent theta burst stimulation (piTBS)
  • +2 more
  • Taipei, Taiwan
    Taipei Veterans General Hospital, Taiwan
Aug 15, 2022

Epilepsy Trial in Toulouse (DIXI Medical Microdeep® Micro- Macro Depth electrodes, Standard electrodes)

Not yet recruiting
  • Epilepsy
  • DIXI Medical Microdeep® Micro- Macro Depth electrodes
  • Standard electrodes
  • Toulouse, France
    University Hospital of Toulouse
Oct 30, 2023

Drug Resistant Epilepsy Trial in Bron, Marseille (blood sample)

Completed
  • Drug Resistant Epilepsy
  • blood sample
  • Bron, France
  • +1 more
Apr 4, 2022

Major Depression Trial (TBS, sham)

Recruiting
  • Major Depression
  • TBS
  • sham
  • Kaohsiung, Taiwan
    Department of Psychiatry, Kaohsiung Veterans General Hospital
Jan 13, 2023

Resistant Hypertension Trial in Guangzhou (Sacubitril/valsartan, valsartan)

Recruiting
  • Resistant Hypertension
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Sep 16, 2022

Epilepsies, Myoclonic, Drug Resistant Epilepsy Trial (Lorcaserin)

Available
  • Epilepsies, Myoclonic
  • Drug Resistant Epilepsy
  • (no location specified)
Jun 1, 2022

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, High Risk

Recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +5 more
  • Gemtuzumab Ozogamicin
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Epilepsy Trial in Shenyang (Everolimus, Placebo)

Recruiting
  • Epilepsy
  • Shenyang, Liaoning, China
    Shengjing Hospital of China Medical University
Nov 5, 2022